Document is current

Article History

Accepted: 17 November 2024

First Online: 23 December 2024

Declarations

:

: No funding was received to conduct the study analysis nor the preparation of the manuscript, with the exception of medical writing support, which was funded by AstraZeneca. The open access fee was also funded by AstraZeneca.

: Ana Pérez Dominguez, Lucía Regadera Anechina, Jorge Marinich, and Inmaculada Iglesias declare being employed and owning stock of AstraZeneca. Marc Cortés has no conflicts of interest to declare in relation to this sudy.

: All data generated during this study are included in this published article.

: All authors contributed to the conception and design of the study, as well as the investigation and analysis performed. The first draft of the manuscript was written by Ana Pérez Dominguez. All authors critically reviewed, edited, and commented on the manuscript until the final version was obtained. The final version of the manuscript was read and approved by all authors.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.